About ZyMot
ZyMot is a company based in Gaithersburg (United States) founded in 2013 was acquired by CooperSurgical in August 2025. It operates as a B2B. ZyMot operates in a competitive market with competitors including Memphasys, Cytoswim and Reproductive Solutions, among others.
- Headquarter Gaithersburg, United States
- SectorsHealthcare
- Email••••••••
- Website zymotfertility.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by CooperSurgical (Aug 2025)
- Investors
- Acquired byCooperSurgical
(Aug 2025)
Investors in ZyMot
ZyMot has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States |
Investor details for ZyMot
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ZyMot
2 dated milestones of ZyMot across 12 years, from founding to its latest funding, stage changes and deals.
- Founded ZyMot is founded.
- Exit Acquired by CooperSurgical.
Competitors of ZyMot
ZyMot operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Memphasys, Cytoswim and Reproductive Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| memphasys.com | 2006 | Homebush, Australia | – | – | Reproductive cell separation techniques for assisted reproduction are developed. | |
| cytoswim.com | 2019 | Coventry, United Kingdom | $129,354 | 4 | Sperm selection tools for assisted reproduction are developed. | |
| rsifertility.com | 2017 | Dallas, United States | $300,000 | – | Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The company's products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics. |
Detailed competitors of ZyMot
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ZyMot
The website of ZyMot (zymotfertility.com) receives about 2K visits a month.
- Monthly visits2K
▲ 1.5% vs previous month
Similar companies to ZyMot
10 companies that operate in the same segment as ZyMot (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ZyMot
ZyMot was founded in 2013.
ZyMot is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
ZyMot, founded in 2013 in Gaithersburg, United States, focuses on providing healthcare solutions, developing medical devices, reproductive health, and sperm separation. Develops innovative sperm separation devices for medical applications. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
ZyMot's top competitors include Memphasys, Cytoswim and Reproductive Solutions.
ZyMot has 1 investor. Key investors include CooperSurgical.
Yes. ZyMot was acquired by CooperSurgical in August 2025.